Inhibition of Cathepsins to Treat Neuroblastoma |
Alfred I duPont Hospital for Children / Robert Mason |
Innovation Grants |
2008 |
Delaware |
Screen to Intervene: A Family-Centered Approach to Identifying and Communicating Family Psychosocial Risk and Developing Evidence Based Clinical Pathways in Hematopoietic Stem Cell Transplantation |
Alfred I duPont Hospital for Children / Anne Kazak, PhD |
Psychosocial Grants |
2015 |
Delaware |
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine / Meenakshi Hegde, MD |
'A' Award Grants |
2016 |
Texas |
Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation |
Baylor College of Medicine / Eveline Barbiere, MD |
Innovation Grants |
2016 |
Texas |
The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy |
Baylor College of Medicine / Sarah Sartain, MD |
Innovation Grants |
2024 |
Texas |
Elucidating the Mechanism of ERK Mediated Pathogenesis of LCH |
Baylor College of Medicine / Rikhia Chakraborty, PhD |
Young Investigator Grants |
2015 |
Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Dissecting and Targeting the Wnt Signaling Pathway in Metastatic Osteosarcoma |
Baylor College of Medicine / Jason T. Yustein, MD, PhD |
Young Investigator Grants |
2013 |
Texas |
Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells |
Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Texas |